A Retrospective Observational Study to Assess Prescription Pattern in Patients with Type B Aortic Dissection and Treatment Outcome

Table 3

Prescribing patterns of nonoperated TBAD patients.

Medication (%)	Before index date	After index date
-blockers	15 (14.2)	85 (80.2)
Selective -blockers	9 (8.5)	71 (67.0)
Atenolol	3 (2.8)	4 (3.8)
Bisoprolol	6 (5.7)	68 (64.2)
Nonselective -blockers	4 (3.8)	5 (4.7)
Propranolol	4 (3.8)	5 (4.7)
- and -blockers	5 (4.7)	10 (9.4)
Carvedilol	4 (3.8)	8 (7.6)
Labetalol	1 (1.0)	2 (1.9)
ACEIs/ARBs	22 (20.8)	54 (50.9)
ACEIs	7 (6.6)	7 (6.6)
Captopril	1 (0.9)	1 (0.9)
Fosinopril	1 (0.9)	1 (0.9)
Imidapril	0 (0)	2 (1.9)
Lisinopril	0 (0)	1 (0.9)
Perindopril	1 (0.9)	1 (0.9)
Quinapril	2 (1.9)	0 (0)
Ramipril	4 (3.8)	2 (1.9)
ARBs	18 (17.0)	49 (46.2)
Candesartan	4 (3.8)	15 (14.2)
Irbesartan	7 (6.6)	18 (17.0)
Losartan	1 (0.9)	5 (4.7)
Olmesartan	6 (5.7)	10 (9.4)
Telmisartan	1 (0.9)	1 (0.9)
Valsartan	10 (9.4)	27 (25.5)
CCBs	25 (23.6)	94 (88.7)
Dihydropyridine	22 (20.8)	92 (86.8)
Amlodipine	17 (16.0)	62 (58.5)
Felodipine	3 (2.8)	1 (0.9)
Lercanidipine	2 (1.9)	5 (4.7)
Nicardipine	1 (0.9)	17 (16.0)
Nondihydropyridine	5 (4.7)	7 (6.6)
Diltiazem	4 (3.8)	7 (6.6)
Verapamil	1 (0.9)	0 (0)
Vasodilator	14 (13.2)	30 (28.3)
Diuretics	16 (15.1)	39 (36.8)
-blockers	6 (5.7)	26 (24.5)
Statins	15 (14.2)	49 (46.2)
Atorvastatin	12 (11.3)	26 (24.5)
Rosuvastatin	5 (4.7)	23 (21.7)
Fluvastatin	1 (1.0)	4 (3.8)
Pravastatin	3 (2.8)	5 (4.7)
Other lipid-lowering agents	7 (6.6)	14 (13.2)
Antiplatelet agents	17 (16.0)	39 (36.8)
Aspirin	13 (12.3)	34 (32.1)
Clopidogrel	10 (9.4)	13 (12.3)
Dipyridamole	4 (3.8)	5 (4.7)
Warfarin	2 (1.9)	2 (1.9)
Antidiabetic agents	6 (5.7)	18 (17.0)